ANGELA OSTROWSKI: Open Payments
NPI 1841932548 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,143 in 49 payments from 13 companies in 2025. Trend: 2023 $1,925 · 2024 $1,917 · 2025 $1,143
Food & beverage: $1,143
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $294 |
| ABBVIE INC. | 7 | $199 |
| Supernus Pharmaceuticals, Inc. | 8 | $140 |
| Janssen Pharmaceuticals, Inc | 6 | $112 |
| Corium, LLC | 4 | $90 |
| Alkermes, Inc. | 3 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Lundbeck LLC | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 2 | $36 |
Products named: Auvelity, VRAYLAR, Qelbree, SPRAVATO, Azstarys, LYBALVI, COBENFY, CAPLYTA.
Industry payments across MS — which companies pay providers there.
